CVKD
Cadrenal Therapeutics, Inc. Common Stock
NASDAQ: CVKD · HEALTHCARE · BIOTECHNOLOGY
$6.67
+19.32% today
Updated 2026-04-30
Market cap
$13.79M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-6.64
Dividend yield
—
52W range
$4 – $17
Volume
0.1M
Cadrenal Therapeutics, Inc. Common Stock (CVKD) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-260.10%
ROA
-116.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2022 | — | $-6.71M | — | — | — |
| 2023 | $0.00 | $-8.36M | — | — | — |
| 2024 | $0.00 | $-10.65M | — | — | — |
| 2025 | $0.00 | $-13.24M | — | — | — |